NIH mobilized national innovation RADx initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new initiative aimed at speeding innovation, development and commercialization of…
Gilead announced results from phase 3 trial of investigational antiviral Remdesivir in patients with severe COVID-19
On Apr. 29, 2020, Gilead announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and…
Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
Emory University helped lead research on drug to treat COVID-19 patients
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…
University of Nebraska Medical Center remdesivir clinical trial show accelerated recovery from advanced COVID-19
On Apr. 29, 2020, hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than…
Catalent signs agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate
On Apr. 29, 2020, Catalent announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby…
Chimerix announced initiation of phase 2/3 study of DSTAT in acute lung injury for patients with severe COVID-19
On Apr. 29, 2020, Chimerix announced initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19…
OPKO Health’s BioReference Laboratories partnership with New York State initiated testing for COVID-19 antibodies
On Apr. 29, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…
Clinical trial began to see if convalescent plasma can treat COVID-19
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
Clinical trial of drug hydroxychloroquine for treatment of COVID-19 began at Montefiore and Einstein
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that they…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
Entos Pharmaceuticals partnered with EpiVax to develop a pan-Coronavirus DNA vaccine
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax. This partnership combined the Entos Fusogenix DNA…
Dutch consortium began production of millions of medical face masks for healthcare professionals in the Netherlands
On Apr. 28, 2020, the Dutch consortium of AFPRO Filters, Royal Auping, and Royal DSM began large-scale production…
Illumina’s donation to Africa Centre for Disease Control expanded capability for sequencing-based COVID-19 surveillance
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
Secarna Pharma entered into cooperation with Guangzhou’s Sun Yat-sen University to develop treatment for SARS-CoV-2 viral infections
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
Sarepta Therapeutics announced research agreement with U.S. DoD to evaluate multiple constructs from proprietary RNA platform as treatments for COVID-19
On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…
Quest Diagnostics launched consumer-Initiated COVID-19 antibody test through QuestDirectﾙ
On Apr. 28, 2020, Quest Diagnostics announced that individuals can purchase COVID-19 antibody testing for themselves online, without…
Albert Einstein College of Medicine invented compound tested in COVID-19 clinical trial
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that a…
INOVIO completed enrollment in phase 1 U.S. trial of INO-4800 for COVID-19 DNA vaccine
On Apr. 28, 2020, INOVIO announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800…
INOVIO and GeneOne reported positive phase 1/2a clinical data with DNA vaccine INO-4700 for MERS Coronavirus
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase…
Six COVID-19 patients treated with RedHills opaganib under compassionate use show objective clinical improvement
On Apr. 27, 2020, RedHill Biopharma provided an additional update on the compassionate use program with its investigational…
Abbottr received Health Canada Authorization under Interim Order to use FreeStyleﾮ Libre System for hospitalized patients during COVID-19 pandemic
On Apr. 27, 2020, Abbott announced that Health Canada authorized use of FreeStyle Libre system, a sensor-based glucose…
Tgen began recruiting volunteer patients for COVID-19 immunity study
On Apr. 27, 2020, TGen, an affiliate of City of Hope is looking for volunteers: individuals who have…
Mateon announced filing of IND with FDA to evaluate antisense drug candidate OT-101 in COVID-19 patients
On Apr. 27, 2020, Mateon Therapeutics announced announced it has submitted an Investigational New Drug application to the…
Edwards HemoSphere platform receives expanded use indication from Health Canada in treatment of COVID-19 patients
On Apr. 27, 2020, Edwards Lifesciences announced that Health Canada approved an expanded indication for use of the…
LabCorp COVID-19 antibody tests available nationwide with no upfront out-of-pocket costs
On Apr. 27, 2020, LabCorpﾮ announced that it will offer antibody tests for the virus that causes COVID-19….
BioAegis demonstrated Gelsolin therapy can quell the cytokine storm and promote tissue repair
On Apr. 27, 2020, BioAegis Therapeutics announced it had published gene expression data in animal studies where recombinant…
Regeneron and Sanofi updated phase 2/3 adaptive-designed trial of Kevzara (sarilumab) in hospitalized COVID-19 patients
On Apr. 27, 2020, Regeneron and Sanofi announced preliminary results from the Phase 2 portion of an ongoing…
Meridian Bioscience simplified COVID-19 sample prep and eliminated dependence on reagents in short supply
On Apr. 27, 2020, Meridian Bioscience announced the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step…
Aegis Sciences doubled capacity for Coronavirus disease 2019 (COVID-19) testing
On Apr. 27, 2020, Aegis Sciences announced expanded capacity to incrementally ramp up to 7,000 tests per day…